Condition
Reperfusion
Total Trials
4
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 2 (2)
Trial Status
Unknown4
Clinical Trials (4)
Showing 4 of 4 trials
NCT06138834Phase 2Unknown
EFfects of Y-6 SUblingual Tablets foR PaTients With AcUte Ischemic StRokE (FUTURE)
NCT05836766Phase 2Unknown
Cilostazol Dexborneol Versus Placebo for Microcirculation Dysfunction After Reperfusion Therapy in Patients With Acute Ischemic Stroke With Large Vessel Occlusion
NCT05179434Not ApplicableUnknown
A Study of Retrograde Reperfusion of Renal Graft to Reduce Ischemic-reperfusion Injury
NCT02423941Not ApplicableUnknown
A Study of Retrograde rEperfusion in Dbd Donor LIver Transplantation
Showing all 4 trials